Application of hla-drb1*04:03 allele in evaluating the risk of drug eruption caused by methimazole

A technology of HLA-DRB1, allele, applied in the direction of determination/inspection of microorganisms, biochemical equipment and methods, etc.

Active Publication Date: 2021-11-09
AFFILIATED HUSN HOSPITAL OF FUDAN UNIV +1
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] But so far, there is no reliable detection method that can predict the risk of drug eruption caused by methimazole

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0033] 1. Sample

[0034] Methimazole-induced drug eruption group (15 patients with methimazole-induced drug eruption, all volunteers with informed consent): the average age of the patients was 43.7±12.6 years, and 13 of them were female; the patients started taking methimazole orally The incubation period to the occurrence of drug eruption was 15.3±5.6 days; the oral dose of methimazole was 10mg-45mg; among the patients, 13 showed urticarial drug eruption, and 2 showed exanthematous drug eruption; among the patients, 5 patients Shortness of breath occurred during the onset.

[0035] Clinical control group (48 patients who received methimazole treatment for three months or more without any adverse reactions, all volunteers with informed consent): the average age of the patients was 44.2±14.9 years, and 32 of them were women.

[0036] The peripheral blood of each volunteer was collected, and the genomic DNA was extracted respectively.

[0037] 2. HLA genotyping

[0038] Take...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses the application of HLA‑DRB1*04:03 allele in evaluating the risk of drug eruption caused by methimazole. The present invention claims the application of the material used for detecting the HLA‑DRB1*04:03 allele in the preparation of the kit. The present invention also protects a kit comprising materials for detecting HLA‑DRB1*04:03 alleles. Functions of the kit: (a) evaluate the risk of the subject’s drug eruption caused by methimazole; (b) evaluate the risk of the subject’s drug eruption caused by methimazole; carry HLA‑DRB1*04:03, etc. Subjects with alleles have a higher risk of drug eruption after taking methimazole than subjects without HLA‑DRB1*04:03 alleles; (c) evaluate whether subjects are suitable for taking methimazole; ( d) Evaluate whether the subject is suitable for taking methimazole; subjects carrying the HLA‑DRB1*04:03 allele are not suitable for taking methimazole.

Description

technical field [0001] The invention relates to the application of HLA-DRB1*04:03 allele in evaluating the risk of drug eruption caused by methimazole. Background technique [0002] Major histocompatibility complex (major histocompatibility complex, MHC) is a general term for all biocompatible complex antigens. MHC is not only related to transplant rejection, but also widely involved in the induction and regulation of immune response. Human MHC is called human leukocyte antigen (Human leukocyte antigen, HLA). The HLA gene complex is located on the short arm of human chromosome 6 (6p21.3), with a length of about 3.6Mb and more than 200 gene loci. The main loci are HLA-A, HLA-B, HLA-C, HLA- DP, HLA-DQ and HLA-DR etc. are highly polymorphic. [0003] Drug eruption refers to the adverse reactions of the skin and (or) mucous membranes caused by drugs entering the human body through various channels. It is the most common adverse drug reaction, with a reported incidence of 1-3%...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C12Q1/6883
CPCC12Q1/6883C12Q2600/106C12Q2600/172
Inventor 骆肖群邢清和熊浩朱沁媛叶红英
Owner AFFILIATED HUSN HOSPITAL OF FUDAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap